MET — MetLife, Inc.

MetLife Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Adjusted Earnings: $1.6 billion, or $2.49 per share; $2.58 per share excluding notable items (up 24% YoY).
• Full-Year Adjusted Earnings: $6 billion, or $8.89 per share (up roughly 10% YoY).
• Adjusted Return on Equity (ROE): 16% for 2025, within the target range of 15%-17%.
• Direct Expense Ratio: Improved to 11.7%, ahead of the five-year target of 11.3%.
• Free Cash Flow: $4.9 billion generated in 2025, part of a commitment to $25 billion over five years.
• Total Shareholder Returns: Approximately $4.4 billion returned via stock repurchases and dividends.

2. Strategic Updates and Business Highlights

• New Frontier Strategy: Focused on growth, capital deployment, and operational efficiency.
• Group Benefits: Added $100 million in new adjusted premiums; voluntary PFOs grew 10% YoY.
• Retirement Solutions: Achieved record pension risk transfer sales of over $14 billion.
• Acquisition of PineBridge Investments: Enhanced asset management capabilities, with MetLife Investment Management (MIM) now managing $742 billion in assets.
• International Growth: Asia sales up 18% and Latin America sales up 12% in constant currency.

3. Forward Guidance and Outlook

• 2026 Adjusted EPS Growth: Expected to maintain double-digit growth.
• Adjusted ROE: Anticipated to remain in the range of 15%-17%.
• Direct Expense Ratio: Expected to rise to 12.1% in 2026 due to the PineBridge acquisition.
• Group Benefits: Projected adjusted earnings growth of 7%-9% in 2026.
• Retirement Solutions: Expected adjusted earnings between $1.6 billion and $1.8 billion in 2026.

4. Bad News, Challenges, or Points of Concern

• Disability Experience: Weaker than expected in Q4, with higher severity and incidents impacting results.
• Variable Investment Income: Fell short of the $1.7 billion target for 2025, primarily due to lower returns from real estate and other funds.
• Surrender Activity: Increased in Japan due to macroeconomic volatility, particularly currency fluctuations.
• Regulatory Changes: Potential impacts from new state-level paid family leave programs could affect market dynamics.

5. Notable Q&A Insights

• Group Benefits Pricing: Positive renewal season with robust persistency and sales growth, particularly in dental and disability.
• Japan Market: Macro volatility is causing temporary fluctuations in sales and persistency; however, MetLife remains optimistic about its competitive positioning.
• Reinsurance Strategy: MetLife is leveraging reinsurance to enhance capital flexibility and support liability growth in retirement solutions.
• AI Impact: While some employment actions are noted, MetLife's diversified client base and product offerings are expected to mitigate risks associated with AI-driven workforce changes.

Overall, MetLife's Q4 2025 results reflect strong operational performance and strategic execution, positioning the company well for continued growth despite some challenges in specific segments and macroeconomic pressures.